Skip to content
Search

Latest Stories

Challenging titles: Taking BMA's lead PDA raises concerns over the term 'pharmacy professionals'

Challenging titles: Taking BMA's lead PDA raises concerns over the term 'pharmacy professionals'
The PDA recognises the similarities between the unwelcome use by the government and others of the terms ‘medical professionals’ in medicine, and ‘pharmacy professionals’ in pharmacy

A judicial review claim launched by the British Medical Association (BMA) against the General Medical Council (GMC) has parallelly intensified Pharmacists' Defence Association's (PDA) scrutiny over the use of the term 'pharmacy professionals'.

PDA has criticised the evolving definition of 'pharmacy professionals,' and the potential risks to patient safety amidst regulatory ambiguity as part of "a far wider agenda."


Concerns stem from what the PDA perceives as a blurring of distinctions between pharmacists and pharmacy technicians as "attempted homogenisation"  by bodies like the General Pharmaceutical Council (GPhC), NHS, and Royal Pharmaceutical Society (RPS).

Raising similar issue as the BMA against the GMC over its use of 'medical professionals for  doctors and Medical Associate Professions (MAPs), Mark Koizol, Chairman of the PDA has said:

"What we are concerned about is a much more dangerous, planned, and strategic direction which impacts upon the safety of patients."

Distinguishing between the role of a pharmacy technician and a pharmacist, the PDA has said that:

"Pharmacy technicians have either completed an NVQ level 3 course or, in most cases were simply added to the GPhC register via a grandparenting route.

"Pharmacy technicians do not participate in a final registration assessment."

Whereas, pharmacists need to graduate "from a four-year university MPharm course followed by a year of supervised foundation training" to then pass a final registration assessment to qualify as a pharmacist.

"As a result, these two pharmacy roles have very different requirements for their underpinning knowledge, competence, and the final quality assurance process before registration," the statement said.

A recurring problem

In December 2023, the GPhC publicly apologised for erroneously referring to pharmacy technicians as 'pharmacists technician'.

This incident highlighted concerns over accurate professional titles and their impact on patient safety and public protection, an issue underscored by the Professional Standards Authority (PSA) on its website.

The PDA claims that they have already written to the GPhC and recently questioned the pharmacy minister, Dame Andrea Leadsom over safety concerns due to "the blurring of the lines between pharmacists and pharmacy technicians but has not received a satisfactory response."

Moreover, when questioned about the use of pharmacy technicians by the Health Select Committee in its Inquiry into Pharmacy, the pharmacy minister gave a defensive response and did not provide "any real assurances on patient safety."

The association has also criticised pharmacists who "continue to participate in this blurring of the lines between roles are doing nothing more than colluding in the demise of their own profession".

"Other professions have already started to challenge the government through the courts and soon the time may come for pharmacists to do the same.," said Koizol.

"The PDA will watch the two existing legal challenges about the use of the phrase ‘medical professionals’ closely to consider what aspects of those cases might be used to challenge the use of the term ‘pharmacy professionals.”

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less